Anomalies in Nef expression within the central nervous system of HIV-1 positive individuals/AIDS patients with or without AIDS dementia complex

Journal of NeuroVirology

Volumn 4, Issue 3, 1998, Pages 291-300

  McPhee, Dale A ^a   Greenway, Alison L ^a   Holloway, Gavan ^a   Smith, Karen ^a   Deacon, Nick ^a   Pemberton, Louise ^b   Brew, Bruce J ^b,c  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antibodies; Central nervous system; Human immunodeficiency virus; Nef

Indexed keywords

NEF PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BLOOD; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS IMMUNITY;

EID: 0031864076     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289809114530     Document Type: Article

References (36)

1. Azad AA, Failla P, Lucantoni A, Bentley J, Mardon C, Wolfe A, Fuller K, Hewish D, Sengupta S, Sankovich S, Grgacic E, McPhee D, Macreadie I (1994). Largescale production and characterization of recombinant human immunodeficiency virus type 1 Nef. J Gen Virol 75: 651-655.
2. Baczko K, Lampe J, Liebert UG, Brinckmann U, ter Meulen V, Pardowitz I, Budka H, Cosby SL, Isserte S, Rima BK (1993). Clonal expansion of hypennutated measles virus in a SSPE brain. Virology 197: 188-195.
3. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996). Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10: 573-585.
4. Ballart I, Huber M, Schmid A, Cattaneo R, Billeter MA (1991). Functional and nonfunctional measles virus matrix genes from lethal human brain infections. J Virol 65: 3161-3166.
5. Blumberg BM, Epstein LG, Saito Y, Chen D, Sharer LR, Anand R (1992). Human immunodeficiency virus type 1 nef quasispecies in pathological tissue. J Virol 66: 5256-5264.
6. Brack-Werner R, Erfle V, Ranki A (1997). Significance of restricted HIV expression for HIV neuropathogenesis: still an unresolved issue. AIDS 11: 251.
7. Brack-Werner R, Kleinschmidt, A, Ludvigsen A, Mellert W, Neumann M, Herrmann R, Khim MC, Burny,A, Muller-Lantzsch N, Stavrou D, et al (1992). Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 6: 273-285.
8. Brew BJ, Rosemblum M, Cronin K, Price RW (1995). AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Annals of Neurology 38: 563-570.
9. Brew BJ, Evans L, Byrne C, Pemberton L, Hurren L (1996). The relationship between AIDS dementia complex and the presence of macrophage tropic and non-syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid. J Neurovirol 2: 152-157.
10. Cattaneo R, Rose LK (1993). Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol 67: 1493-1502.
11. Gumming SA, McPhee DA, Maskill WJ, Kemp BE, Doherty RR, Gust ID (1990). Use of conserved immunodominant epitope of human immunodeficiency virus surface glycoprotein gp41 in the detection of early antibodies. AIDS 4: 83-86.
12. Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont L, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J (1995). Genomic structure of an attenuated quasispecies of HIV-1 from a cohort of a blood transfusion donor and recipients. Science 270: 988-991.
13. Michael NL, Chang G, D'Arcy LA, Ehrenberg PK, Mariani R, Busch MP, Birx DL, Schwartz DH (1995). Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J Virol 69: 4228-4236.
14. Michael NL, Chang G, D'Arcy LA, Tseng CJ, Birx DL, Sheppard HW (1995). Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression. J Virol 69: 6758-6769.
15. Myers G, Korber B, Halm BH, Jeang K-T, Mellors JW, McCutchan FE, Henderson LE, Pavlakis GN (1995). Human Retroviruses and AIDS, Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
16. O'Brien WA (1994). Genetic and biologic basis of HIV-1 neurotropism. In: HIV AIDS and the Brain. Price RW Perry SW (eds). New York: Raven Press Ltd; pp 47-70.
17. Otake K, Fujii Y, Nakaya T, Nishino Y, Zhong Q, Fujinaga K, Kameoka M, Ohki K, Ikuta K (1994). The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells. J Immunol 153: 5826-5837.
18. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M (1997). A model for monocyte migration through the bloodbrain barrier during HTV-1 encephalitis. J Immunol 158: 3499-3510.
19. Price RW, Brew B (1988). Infection of the central nervous system by human immunodeficiency virus. Role of the immune system in pathogenesis. Ann NY Acad Sci 540: 162-175.
20. Price RW, Brew B, Sidtis L, Rosenblum M, Scheck AC, Cleary P (1988). The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586-592.
21. Ranki A, Lagerstedt A, Ovod V, Aavik E, Krohn KJ (1994). Expression kinetics and subcellular localization of HTV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch Virol 139: 365-378.
22. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K. (1995). Abundant expression of HIV-1 Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9: 1001-1008.
23. Sabatier JM, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, Bahraoui E (1991). Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 65: 961-967.
24. Saito Y, Sharer LR, Epstein LG, Michaels J, Mintz M, Louder M, Golding K, Cvetkocitch TA, Blumberg BM (1994). Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissue. Neurology 44: 474-481.
25. Shugars DC, Smith MS, Glueck DH, Nantermet PV, Seiller-Moiseeiwitsch F, Swanstrom R (1993). Analy-sis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol 67: 4639-4650.
26. Singer EJ, Syndulko K, Fahy-Chandon B, Schmid P, Conrad A, Tourtellotte WW (1994). Intrathecal IgG synthesis and albumin leakage are increased in subjects with neurologic disease. J AIDS 7: 265-271.
27. Suryanarayana K, Baczko K, ter Meulen V, Wagner RR (1994). Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J Virol 68: 1532-1543.
28. Takahashi K, Wesselingh SL, Griffin DE, McArthur CJ, Johnson RT, Glass JD (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Annals of Neurology 39: 705-711.
29. Tornatore C, Meyers K, Atwood W, Conant K, Major E (1994). Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J Virol 68: 93-102.
30. Trujillo JR, Navia BA, Worth J, Lucey DR, McLane MF, Lee T-H, Essex M (1996) High levels of anti-HIV-1 envelope antibodies in cerebrospinal fluid as compared to serum from patients with AIDS dementia complex. J AIDS 12: 19-25.
31. Watson I, Jenkins L (1987). Errors in estimating urinary protein by use of benzethonium chloride. Clin Chem 33: 2127-2128.
32. Werner T, Ferroni S, Saermark T, Brack-Werner R, Banati RB, Mager R, Steinaa L, Kreutzberg GW, Erfle V (1991). HTV-1 Nef protein exhibits structural and functional similarity to scoprion peptides interacting with K+ channels. AIDS 5: 1301-1308.
33. Wiley CA, Achim CL (1997). No evidence of significant abortive HIV infection of the brain. AIDS 11: 252.
34. Wiley CA, Baldwin M, Achim CL (1996). Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10: 843-847.
35. Willey RL, Smith DH, Lasky LA, Theodore TS, Moss B, Capon DJ, Martin MA (1988). In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 62: 139-147.
36. Wilson KM, Gerometta M, Rylatt DB, Bundesen PG, McPhee DA, Hillyard CJ, Kemp BE (1991). Rapid whole-blood assay for HIV-1 seropositivity using an Fab-peptide conjugate. J Immunol Meth 138: 111-119.